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I IN~RODUCTION AND HISTORICAL REVIEW 
The ~ibrinolytic property of blood was ~irst noted by 
Dastre (7) in 1893 when he deseribed the lique~action of a 
~ibrin clot a~ter it stood ~ serum ~or 18 hours. Hedin (17) 
observed that the euglobulin fraction of plasma possessed the 
blood's proteolytic property. The addition of eF!Gls' to serum 
was demonstrated by Delezenne and Pozerski (1903), to activate 
a proteolytic enzyme, and Tagnon (9) demonstrated that this 
ehloro~or.m-activated enzyme was similarly present in the acid-
insoluble euglobulin fraction o~ blood •. Tillet an.ci Garner (37) 
found that bacteria-free ~iltrates o~ cultures of beta-hemolytic 
streptococci contained a water soluble substance which could not 
be dialyzed and Which aided rapid lysis of plasma or fibrin 
clots. T.his fibrinolytic property was found by Milstone (24) 
to depend on the presence of a ttlytic factor"· (i.e .. , plasmino-
gen) in the euglobulin fraction o~ plasma. Plasminogen has 
been shown to be de~icient in the plasmas of the bovine (12,15) 
and rabbit (39) species and it has been demonstrated that 
streptococcal fibrinolysis will occur only in the presence of 
this plasma component (24). Remmert and Cohen (30) found that 
plasminogen has a pronounced tendency to precipitate with other 
proteins, and this results in its distribution into the various 
blood fractions.. Consequently, bovine fibrinogen and bovine 
thrombin are used in determining plasminogen activities to pre-
vent incorrect fibrinolytic assays due to plasminogen contamina-
tion of a fibrinogen preparation. Christensen {5) reported that 
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in the presence of the active enzyme (i.e .. , plasmin.), both the 
plasminegen and plasmin are destroyed. Remmert and Cohen (30) 
and ethers, therefore~ did net attempt to purify the active 
serum protease, as they suspected it would prove unstabie. 
Kaulla (22) h0wever, reperted that "acid plasm.intt, capable of 
liquefying a clot from human plasma in a few hours, is stable in 
the powdered form for menths, but that its solutions rapidly ~ose 
their activity at room temperature. Plasminogen activity was 
reported to be completely destroyed by heating for 3 minutes in 
4> 80 a. water bath(33). 
Kaplan (21), Christensen and MacLeod (35) and Ratnoff (27) 
found that the same plasma fraction contains the 11lytic factern 
\ 
and the chloroform-activated proteolytic enzy.m.e, affor<iing 
strong evidence that the fibrinolytic property of streptococcal 
filtrates was identical with the chloroform-activated enzyme. 
Kaplan (20) suggests that the kinase reaction may be regarded 
as analogous to the transfor.mation of trypsinogen to trypsin 
via enterokinase. Another hypothesis for explaining the mech-
anism of activation is the dissociation of a cempound anala-
gous to the trypsin:trypsin-inhibitor complex in a strong acid 
medium. In fact, Kaulla {22) suggests that in his uacia-plas-
min fraction, precipitated from an euglobulin solution at 
pH.::11o 1.2 via ice-cold acetone, nthe inhibitory compound has a 
relatively low molecular weight and probably remains in solu-
tion during the precipitation with acetone.n Loomis, George 
and Ryder (23) found that plasmin 1'is an euglobuJ.in-water in-
soluble, saline soluble non-<ilalyzable protein enzyme. Its 
iii 
point o~ min~um solubility is near pH~5.5." These same authors 
also ebserved that thrombin is immune to the proteolytic action 
of plasmin~ and that while plasmin. destroys fibinegen and fibrin 
it does not clot fibrinogen. It was also found (32) that plas-
min is able to digest prothrombin. 
Plasminogen activation via the streptoeocc.al. exotoxin (i.e., 
streptokinase) occurs almost instantaneously (2,21), [i.e., clot. 
lysis time:::. 6 minutes (15)], but the same activation reactien 
employing staphylococcal filtrates is considerably slower, com-
plete lysis occurring in 3 hours (15). Tillet and Garner (38} 
proved that the streptococcal factor (i.e., streptokinase) does 
not act as a proteolytic enzyme by itself, but merely serves as 
a kinase activator for the plasma precursor. Similarly, the 
staphylococcal .factor is not a protease in its own right (15). 
It appears evident that .fibrinolysis via the addition to serum 
of either chloroform, strepto- or staphylokinase occurs through 
the activation o.f the same serum .fraction, namely, plasminogen; 
the difference in clot lysis time in the presence o.f a particular 
kinase, probably due either to a difference in the time required 
.for activation or to incomplete activation, may indicate a 
Qif.ference in the activation mechanism .for the respective act!-
vators. 
Goodpasture{l6) suggested that rapid fibrinolysis in patients 
with liver disease was due to a decrease in the concentration o~ 
an inhibitor e.f plasma proteolytic enzyme rather than an excess 
of the enzyme itself. The addition of nermal plasma to patients 
with atrophic cirrhosis prevented rapid clot lysis. The inb.ib-
iv 
itory activity of plasma was found to decrease upon incubation 
0 
at 37 C., and the clot lysis time was feund to be related to 
the deterioration of the unstable inhibitor (28). Ratnoff (28) 
also found that in patients whose clots lysed rapidly, the ~­
hibitory activity of the plasma, serum or albumin reached a 
minimum more rapidly than normally, but that after fibrinolysis, 
little or no further decrease in the amount of the inhibitor pre-
sent occurred; however, the inhibition was not completely de-
stroyed. In this manner the clot lysi~ time has been correlated 
with the decrease in inhibitory activity against the activated 
enzyme. Fibrinolytic activity has been seen in patients with 
liver diseases, in toxaemia 0f pregnancy, in shock, in violent 
death, during surgical operations and in the course of resorption 
of thrombin (22). The rapid digestion of fibrinogen in vivo may 
lead to f allure of the hemostatic mechanism (55). 
Christensen { 3,4) and Christensen and MacLeod (5) ascer-
tain that plas.min is not identical with trypsin. They found 
that plasmin is distinct from trypsin in its pH of optimum 
activity, its reactions with specific protease inhibitors and 
in its reactions on a casein substrate; in the latter experiments 
it was demonstrated that trypsin can continue the hydrolysis of 
casein after hydrolysis by plasmin is complete. Kaplan (20) re-
viewed the literature pertaining to a comparison of the proper-
ties of plasmin and trypsin; this author demonstrated that the 
two enzymes were not identical. The evidence for this conclu-
· sion was based on the distinct specificities of their kinases; 
i.e., strepto-or staphylokinase and·enterokinase respectively. 
The respective kinases were found to be highly specific. Also, 
............ ---.-.---.--.................................. . 
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the antibodies to plasmin were found ~effective on enterokinase. 
Plasminogen cannot be assayed directly, but must first be 
activated into plasmin. T.he plasminogen may be activated via 
several methods. Christensen (3, 4) prepared serum fractions by 
dilution and acidification to pH 5.3 and by l/3 saturation with 
(NH1)~SO~ and found them to develop proteolytic activity without 
the addition of kinase or chloroform after a variable period of 
aging in the cold, when the inhibitor content is low. Incuba-
tion also causes.activation (35). Chloroform or ether treat-
ment presumably abolishes the activity of the irihibitor and 
actigation of plamninogen takes place (35), presumably by auto-
catalysis (3). Strepto- or staphylokinase activation, however, 
occurs in a matter of minutes (12, 3) even in the presence of 
plasmin inhibitor (35). Schmitz (31) obtained activation by 
treatment with trichloroacetic acid. Most significantly, how-
ever, Astrup and Fermin (1,2) reported that aqueous extracts of 
certain tissues are able to activate plasminogen into plasmin. 
These authors found fibrinokinase (the tissue extract) from 
pig1 s heart to be inactive on chicken fibrinogen and fibrin. 
Upon incubat~g the pig fibrinokinase with ox pro-enzyme, the 
solution eXhibited lytic activity on the chicken fibrin. The 
specificity and kinase activity of the tissue eXtract on a 
blood fibrinolytic enzyme was thus demonstrated. These authors 
also d~onstrated that ox serum contains only one pro-enzyme 
which is activated by means of.fibrinokinase, While human 
plasma possesses two pro-enzymes, one of whicih is activated by 
fibrinokinase and the other by streptokinase. Tagnon and 
Palade (35) found a fraction obtained by differential centri-
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fugation from a suspension of rat lung tissue to be able to 
activate plasminogen into plasmin. These authors suggest 
that the activation is a kinase acting on the substrate plas-
minogen to transform it into plasmin. 
Plasminogen has been isolated and partial~y purified by a 
variety of procedures. Low temperature ethanol-water mixtures 
(6} and alting out via (NH~)~SO~ and NaLSO~ (35), though re-
sulting ~ the dispersal of plasminogen into several fractions 
(30) have been employed. The Remmert and Gohen (30) procedures 
and others utilize dialysis followed by isoelectric precipita-
tion at several ionic strengths and adsorption and elution 
from kaolin. Remmert and GOhen (30} assert purification of 
pla~nogen by a factor of 136 to 165 compared to the original 
human serum. Schmitz (31) has employed trichloroacetic adid ~ 
~ractionation procedures as well as adsorption on Oa-f'ibrin. 
Remmert and Gohen ~30) present an analysis of several of these 
procedures. 
Shinowara (33) and Milstone (24) reviewed several of the 
methods employed in assaying plasminogen activity. Among those 
listed are the following: (aJ the liquefaction of a fibrin 
clot (24); (b) the hydrolysis of casein as measured by either 
an assay of the acid soluble tyrosine and/or nitrogen produced 
or, an assay of the precipitatable protein performed turbid~et­
rically before and after digestion (26, 27, 28); (c) the alter-
ation of fibrinogen as measured by the increased clotting time 
l 
with thrombin (12) (i.e., ttfibrinogenolysis"); (d) the hydrolysis 
of hemoglobin and also (e) an assay of the change in gelatin 
viscosity as determined via a aecrease in efflux time. Remmert 
---
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and Cohen (30) t:ested the activities o:f plasmin samples against 
casein and :fibrin clots. These authors obtained considerable 
caseinolysis and :found that the two· plasminogen preparations 
employed, though differing in purity by a :factor of 17.6, exhib-
ited the same ratio o:f activities twward the casein and :fibrin. 
Tb.ey suggest that human serum contains only one proteolytic 
enzyme activated by streptokinase. Shinowara {33) ~ however, 
suggests that tithe liquefaction of a :fibrin clot, the altera-
tion of :fibrinogen as measured by clotting t~e with thrombin, 
the change in gelatin viscosity, and the increase in acid sol-
uble nitrogen are not representative of an identical enzyme 
systam." Re.mmert and Cohen (30) :found that the plasma o:f human 
serum does not hydrolyze hippuramide. 
Walker, Derow and Schaffer (40) have reviewed the litera-
ture pertaining to~e coagulative aiding property of :filtrates 
of' staphylococci. In an earlier paper (41) these same authors 
titrated coagulase activity by a serial dilution procedure in 
which- 0.5 m1 o:f each dilution was mixed with an equal volume 
of' fresh, sterile human plasma. .Stapnylocoagulation is produce« 
by a bacterial product, prostaphylocoagulase, plus a plasma co-
f'actor other than prothrombin (15) • The term staphylokinase is re-
served :for the second factor Which acts like streptokinase {15). 
Gengou (14) :found staphylocoagulase extremely resistant to ther-
mal inactivation. Walker, Schaffer and Derow (41) conf'irmed the 
complete destruction of coagulase activity by trypsin or pep-
sin, and also verif'ied its stability when heated. ( 120'0. does 
not abolish the coagulase activity). However, Gerheim, Ferguson 
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et al (15) demonstrated the separability of the coagulative and 
lytic aiding properties associated with staphylococci by virtue 
of the fact that incubation at 75°0. for 2 hours resulted in a 
complete loss o:f coagulase activity while the lysis time of the 
preparation was little altered. These authors proposed the term 
"staphylocoagulasen :for the active coagulant and 11prostaphylo-
coagulase" for the bacterial product. 
From a teleological point of view, two hypotheses have 
recently been o:ffered to explain the presence of a potentially 
active fibrinolytic enzyme in plasma. Nolf (25) suggested 
that proteolysis is an essential step in the clotting of blood 
and the observation that pancreatic trypsin clotted oxalated plas-
ma {8) seemed to supporthis theory. However, the proteolytic 
en~e prepared from plasma which was deficient in the known 
clot-promoting substances did not possess such thromboplastic 
activity (29). It is therefore apparent that the clot-promot-
ing property is not related to the presence of the plasminogen 
or plasmin, but is rather a function o:f the clot-promoting sub-
stances fractionated with it from the plasma. 
The second hypothesis deals with the physiological activa-
tion of plasminogen in the organism and is discussed by ~agnon, 
Davidson and Taylor (36) and by Ratnoff, Hartman and Oonley (29). 
Tagnon and Palade (35) suggest that the tissue activator may 
provide the mechanism by Which blood clots formed in tissues are 
eventua.J.ly resorbed. Some tissues ( i.e., liver tissue) are 
deficient in the activator (35). 
Nomenclature ( 27, 5, 10, 23, 30) 
The fibrinolytic enzyme of plasma or serum has been calleEl 
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plasma protease, tryptase, trypsin, fibrinolysin, plasmin or 
proteinase. The te:r.m "plasmin 11 will be used throughout. The 
precursor ot this enzyme has been variously termed plasminogen, 
tryptogen or profibrinolysin; nplasminogenn will be used here .. 
The activAting principle obtained from beta-hemolytic strepto-
cocci and originally called fibrinolysin will be termed "strept-
tt 
okinase; similarly, the staphylococcal activator will be desig-
nated ustaphylokinasen. The precursor, when activated by either 
chloroform, strepto- or staphylokinase, or via spontaneous ac-
tion will be designated as nplasminu as the active principle in 
each instance is thought to be identical. The ter.m "enzyme" as 
used in this paper will mean the crude, partially fractionated 
enzyme preparation, and not a single purified substance. Anti-
fibrinolysin or antiplasmin is the naturally occurring plasma 
or serum fraction that inhibits the activity of plas.min. 
Assays 
~ of fibrinolytic activity: Since there is no set unit 
for plasmin activity (23), one was defined here as follows: 
one unit of fibrinolytic activity is the highest dilution of 
the staphylococcal preparation which will completely lyse a 
fibrin clot (prepared via .a ml of a bovine fibrinogen, 
Fraction I, solution containing .44 gms/lOOml q. s. 1.5ml 
to which 2 drops of a bovine thrombine solution are added) at 
37°0. in 3 hours in a .lM puosphate- .9% NaCl buffer, pH~7.4. 
U~t ot caseinolytic activity: Caseinolytic activity was 
expressed as mg of tyrosine liberated after a one hour incuba-
tion period at 37°Ce due to the plasmin activity in a 0.7 % 
casein solution. The plasminogen was initially completely activ-
X 
ated by the preliminary incubation of the plasminogen with its 
kinase at 5?PO. for l l/2 to 2 hours. 
II Statement ,!! the Problem 
T.he principal objects of this study are to verify mebhods 
for the purification of plasminogen via fractionation from horse 
serum and to determine plasmin activity on casein and fibrin 
substrates in order to ascertain the relationship between the 
two activities. A comparison between a procedure yielding the 
inactive proteolytic precursor [1. e., Remmert and Cohen {30~ 
and the active "acid-plasminn [Kaulla (22>] is performed. T.he 
kinase employed in all ·assays was prepared from a culture of' 
staphylococcus aureus. 
' . 
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III Materials and thei~ Preparation 
A. Partial puri.fication o.f plasminogen 
A 500 m1 s~ple o.f partially hemolyzed, nor.mal horse 
serum, prepared 6/19/50 by the Antitoxin and Vaccine Labora-
tory, Boston, Mass., was divided into three portions as 
.follows: 
1: 10-cc for the preliminary tests; i.e., to determine 
1 the initial concentration and activity or the plasminogen in 
the unfractionated horse serum; 
2: 220 cc .for the isolation and partial puri.fication of 
the fibrinolytic precursor, plasminogen, via the procedure or 
Remmert and Cohen ( 30) , and .finally 
l 
3: a 22Q co aliquot for the preparation of "acid-plasminn 
as suggested by Kaulla (22) and said to be the active principle 
isolated .from its serum inhibitors. The procedures numbered 1 
and 2 above will be .found outlined in .figures la and lb respect-
ively. 
At every point in ei t\ter ease where the discarding o.f a 
supernatant .fraction is designated, the solution or mixture, as 
the case may be, was placed in the refrigerator for 48 hours. 
At the end of this period, whicn was to allow .for complete pre-
cipitation, the pH was rechecked and readjusted if necessary, 
and the precipitate obtained upon centrifugation combined with 
the fraction obtained 48 hours earlier .from the same mother liquor. 
All preparations of plasminogen and its bacterial exotoxin 
activator, staphylokinase 1were kept in the refrigerator when not 
in use, and all tests were prepared and conducted at ±Joom temper-
ature except where otherwise stated. 
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B Partial Puri~ication of Staphylokinase via Method of Blau-
stein ~pre-doctoral work) --- -- ----
Plasminogen in blood p1.asma, serum or in partially puri-
fied fractions cannot be assayed directly but must first be 
activated into plasmin. Streptokinase, kindly prepa.red by 
Dr. Weinstein o~ the Haynes Memorial Hospital, Boston, Mass., 
was used in the preliminary activation tests., as complete 
activity via this kinase is practically instantaneous and com-
plete lysis occurs within a six minute incubation period (19). 
However, this particular preparation proved inactive (also, it 
was highly insoluble), and consequently the slower acting 
staphylokinase was prepared to serve as activator in all the 
experiments. The staphylokinase is slower acting than the 
streptococcus exotoxin, but it does produce complete clot ly-
sis in three hours (19). 
A stock culture of Staphylococcus aureus was obtained 
through the courtesy of E. Blaustein (pre-doctoral candidate 
at the Boston University Graduate School of Bacteriology), and 
the kil;ase was partially purified via the procedure he employed 
in his pre-doctoral studies (unpublished); the culture media con-
sisted of 15 gms. casamino acids and 5 gms. yeast extract in one 
liter of distilled water and the mixture adjnsted to pH== 7 .8. 
The method of preparation is outlined in fig. 2 below. The 
:t'inal. fraction, brown in. color, was <lis solved in .1M Po;- • 9% 
NaCl. buffer, pH=7.4, 1/10 the volume of the culture filtrate. 
It was not Wholly soluble, but it did produce a fairly uni:t'o~ 
m,ixture when thoroughly shaken before use, and it proved quite 
active on a s~ple of human plasma known to contain plas~nogen. 
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G Preparation of Substrates 
l.Casein 
a. Preparation 
Unhomogenized milk was centrifuged, and the fatty layer was 
discarded. The remaining fraction was adjusted to pH=4.7 with 
dil .. H Gl and the casein precipitate allowed to settle. After 
decantation of the supernantant, the precipitate was dissolved 
several t~es in water to which dil. NaOH was added and reprecip-
itated by the addition of.dil. RCl. T.he casein precipitate was 
next filtered, washed several times with water and then suspended 
and stirred in 95_% ethyl alcohol. This mixture was again filtered, 
and the easein pressed between filter papers to re.move the alco-
hol and water. The casein was next suspended in ethyl ether and 
stirred and heated over a water bath. The ether-casein mixture 
was again .filtered and allowed to dry in~ir. 
For use, the purified casein was dissolved in .lMPOlf:_ .9_% 
NaGl buffer, pH~7.4, ana the entire solution adjusted to pH~7.4 
with dil. NaOH. The solution was then heated 15 min. in a boil-
ing water bath, filtered and·the pH readjusted to 7.4. Amicro-
Kjeldab.l-Nesslerization determination was next performed on 
one ml of a 1 ml q.s 35 m1 and a 1 q. s. 50 dilution of' the 
solution, and the latter was subsequently diluted t9 obtain 
approximately a .9 to 1.% casein solution. All readings were made 
at~-= 515. 
Stock standard of' (NH'r)::L SO 'f:' 
blank"="\!ml distilled water+.5cc digestion mixture+ 15cc NesslertiJ 
q. s. 50 mls e. distilled water 
standard ::If. ml containing .14 N/ml +'. 5ee digestion mixture r 
15cc Nessler's] q.s. 50 mls 6 distilled water 
ease in 
solutions' 
[1 m1 of' l q. s. 35 dilution 1- • 5m1 digestion 
misture+ 15ml Nessler• s] q. s. 50 mle;distilled water 
[1 ml of .1 q. s. 50 dilution + .5 m1 digestion 
mixture+ 15ml Nessler' sJ q. s. 50 ml c; .distilled 
water 
Results 
-1 ::.515 
reading of blank ~ 100% Transmittance 
reading of standard (.f"3N~l) "' 76.5% T 
reading of 1/35 dilution of casein so1~2.o% T 
reading of 1/50 dil. of casein sol. ~68.5% T 
reading of stand. t.. 
reading of un.known. 
mg N/ml in stand.Xdil.-=- mg N present in 
casein solution 
76.5 )( 
52.0 .11(.35 ::: 5.3-
~~ . 68.5 .1)(35::;. 5.5 
av. ::t574 mg N/!!9: in 185 ml of casein sol. 
j 
185 ml i. 5,.4 ~g N/ml = 999 mg N-. • 999 gm.s N in 185 ml of casein sol. 
no. oi gms of casein present =-1 ~ 100 
16.4 = 6 .. 1 gms. of casein in 
185 mls of solution 
(6.1 gms of casein) q. s. 650 m.l---?.94% casein 
lb. Preparation 2t tyrosine calibration curve 
A tyrosine stock standard in 0.1 N HGl and containing 
l mg/ml was diluted as indicated below (fig. 3) with 0 .. 1 N HGl. 
A lml aliquot of each dilution in a Coleman Jr. Spectrophoto-
meter tube was treated with 6m.l clear 12.5% Na'l.ao~ and l ml 
I 
of the prepared Folin-Ciocalteu reagent diluted 1!2 and the 
~ 
resulting solution incubated for 10 to 15 minutes at 37 c. for 
complete color development. These tubes were read against a 
blank set at lOO% T containing l ml 0.1 N HGl~ 6 ml 12.5% Na~C03 
and l :mJ. o:f the phenol reagent at,J::-650 in the Coleman Jr. 
~pectrophotometer. 
Fig. 2 Preparat~on Qt ~ ~osine Cal~brat~on Curve 
Stock standard=-1 mg tyrosine 
ml 
Dilution of 
stock standard 
1.::13 ............ . 
l:~4 ........... . 
~:18 .•••.....•.. 
1:~9 ..•......•.• 
1:24 .•.•..•..... 
~:29 •••.•....•.. 
~ :30 •. ....•...•. 
1:34 ••....•...•. 
1:35 •••••••••••• 
1:39 •...•••••••• 
.5:29.5 .•..... ..• 
.5:34.5 .......•• 
.5:35.5 ••.•...•. 
.5:3915 ••••••••• 
.5: 49.5 •••••••• 
.5:99.5 ••••••••• 
.J tyrosine/ml 
?~.4 ........... 
66.7 •....... ..•• 
52.7 ......•.•.. 
50.0 ......•••.. . 
40.0 ............ 
33.3. •· ..••....• 
32.25 ............ 
27.1 .... ~ .....• 
2?.8 ............ 
25.0 •••...•••.. 
16.6 •.••••••••• 
14e·3_. • • • • • • • • • • 
13.9 •••.••••••• 
'12. --5 •••••••••.•• 
10.0 ............ 
s.o ............ 
Reading 
15.0 
16.0 
22.5 
27.7 
32.5 
41.0 
42.5 
49.0 
49.5 
50.0 
63.0 
67.5 
68.5 to 69.0 
69.5 to 70.0 
72.5 to 73.5 
84.0 to 85.5 
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2. Fibrin Clot 
a. """'"Fibrinogen 
220 mg o~ bov~e ~ibrinogen, ~raction I, was 
dissolved in .85,% NaCl. The :f."ibrinoge:a. was brought under a high 
vacuum and 50 ml o~ .85,% saline were ~troduced via a 50cc sy-
r~ge. This procedure was necessary as the :f."ibr~ogen is not 
readily soluble at atmospheric pressure. 
b. Thrombin 
Powdered bovine topical thrombin concentrate, 
diluted just be~ore use with isotonic saline and containing 
1000 N.I.H. units per ml was used. ~o to three drops were used 
to produce a solid clot. 
.. 
'. 
IV Pr0ced.u.re and Tabulation of Results ~~~~~--.~~~-
A. Caseinolysis 
1. Introduction 
The hydrolysis of casein was measured by the 
liberati~ of tyrosine and determined eolormetrically by the 
method of Folin and Ciocalteu (13). The procedures ~ployed 
were modified from Shinowara (33), Remmert and Cohen (30), 
Ferguson and Lewis (11), Heidelberger and MacPherson (18) 
and Ratnoff (28}. The plasminogen was incubated with a pre-
determined excess of the staphylokinase for 1 1/2 to 2 hours at 
• 37 C. for the complet~ activation of the lytic factor. At the 
end of this period the .9% to 1% casein solution was added and 
five minutes from the time of this addition, a 2 ml aliquot was 
withdrawn and the hydrolysis stopped by the precipitation of the 
protein in 2 ml 10% trichloroacetic acid. Hiller and Van Slyke 
(19) found that increasing the concentration of trichloroacetic 
acid increases the precipitation or non-protein nitrogen cam-
pounds. The untreated solution was placed in the incubator at 
37°0. for a 60~mdnute period, while the precipitated aliquot, 
whose time of withdrawal was recorded as ·uzero minutesrt, was 
placed in the frigerator for 20 to 30 minutes, for the complete 
precipitation of the casein. The casein was next r~oved via 
filtration through Whatman folded filter papers #12, and a 1 ml 
aliquot of the digestion filtrate was placed in a Coleman Junior 
Spectrophotometer cuvette containing 1 ml 5% trichloroacetic 
acid. These tubes were allowed to stand till the ti6o.:minuteu 
aliquots were similarly prepared. 
II 
p 
At the end o:f the one hour incubation at 37 c., a second 
2 m1 a.J.iquot was withdrawn and pipetted into 2 mls o:f 10% tri-
chloroacetic acid and treated in the same manner as the nzero 
minutett aliquot above. With the two sets o:f tubes all prepared., 
6 ml o:f 12.5% Na~CO~and 1 m1 o:f the Folin-Ciocalteu reagent 
(diluted 1:2) respect.ively were added to each tube and the color 
value o:f the digestion :filtrate was then read at..( ... 650 in terms 
o:f mgms. o:f pure tyrosine as .determined :from the calibration 
curve in :figure 3. 
Two control tubes were s~ultaneously run with each set o:f 
determinations. The necessity for two controls was de.monstrated 
by Shinowara (33). One control contained the 4 ml o:f the casein 
' 
solution and the second contained the kinase and plasminogen; 
both were diluted up to volume with P04-::.- saline buffer, pH::.7 .• 4. 
The enzymatic activity in all runs was expressed as mg o:f tyro-
sine liberated per digestion mixture by substrating the amounts 
:found in the enzyme and substrate controls :from that :found in 
the enzyme-substrate mixture (33). The zero minute result thus 
obtained subtracted :from the 60-minute run would then indicate 
the proteolytic activity exhibited by the np1asmin 11 preparation 
upon the casein substrate. 
2.. Procedure 
T.he :first caseinolysis experiment was performed on 
a sample o:f the un:fractionated horse serum to· determine its 
initial proteolytic activity. Three control and three test 
runs were performed simultaneously in a series o:f Wasserman 
tubes as :follows: Control # l initially contained .3 ml o:f 
the .9 to 1% casein solution, 1.0 ml PO~~saline buf'fer[pH ... 7. 
but neither staphylokinase nor plas.minogen was added --this 
control allowed for the determination of the hydrolysis of 
casein solution during the one hour incubation test period; 
Control #2 initially contained 4.6 ml of' the buffer, .2 ml 
the unfractionated serum (source of the plasminogen) and 
of the kinase--the hydrolysis products oft he kinase. and 
serum protein during the one-hour incubation may now be 
The third and final control tube contained the casein and 
plasminogen source but no kinase was added, in order t~deto~~~uo 
· any caseinolytic activity due to the spontaneous activation 
the plasminogen (in the absence of any activator). 
The t~ee test runs were simultaneously prepared 
the first and second Wasserman tubes contained .3 ml of the 
casein solution, .6 ml buffer followed by.2 ml horse serum 
(plasminogen source} and • 2 ml staphylokinase.. In order to de-
termine if the .2 m.l of' staphylokinase was actually in exce s 
of the plasminogen present (to insure complete activation), 
the third test run was performed with the same volumes of 
casein solution and plasminogen source, but with .4 ml of 
kinase and .4 ml of buffer to dilute to volume. The final 
volume in all tubes was now 1.3 ml, except for control-#2, eh 
anticipated the fina~volume of 5 mls. 
All tubes were simultaneously incubated at 37°a. for 1 l/2 
hours to allow for plasminogen activation, and then, but 
control 12, 3.7 ml of the casein solution was added to each 
The volume in each tube was now 5 ml, which meant that the 
13 
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uplasminu would be acting in a .7% casein medium.. 
At the end of f'ive minutes a: 2 ml aliquot was withdrawn 
h t be and t reated with 2 m1 10% trichloroacetic to from eac u 
stop the reaction. The resulting ppt. and its untreated mother 
liquor were treated and.test~d as outlined in fig. 4. 
:_. ~i, ...... · 
r ll 
Ill · . 
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Other caseinolysis experiments were similarly per:Cor.med 
with the Rammert and Cohen preparation as the p1amninogen 
source. The results are all shown in f'igure 5 below. 
-- ~--
1 
These results indicated that a two-f'old increase in the 
kinase volume added did not result in any increase in the ac d-
- I 
soluble tyrosine produced in a • 7% casein. medium,. thus demonftrat-
ing that the kinase was already present in excess. The casefn-
olytic activity of' the uplasminu, as assayed via the acid-so -
uble tyrosine produced af'ter a 1 1/2 to 2 hour prel~inary a ti-
vation period with its kinase followed by a one hour test period 
of' "plasmin" proteolytic activity in a .7% casein medium, ha not 
been demonstrated. Tb.e possibility that either the kinase o 
the plasminogen source (R~ert and Cohen prep.) or 
inactive may be ruled out, as these same preparations were l 
demonstrated to completely lyse f'ibrin clots in f'rom 3 to 4 
~e spontaneous activation of' plasminogen in C # 3 cannot 
onstrated either. This lack of' nplasminu caseinolytic activ 
ity when contrasted with its potent fibrinolytic activity se s 
to indicate that the two processes are not due to the same e -
zyme activity. 
B. Fibrinolysis 
The methods employed ~or the demonstration of f'ibr 
olysis were slightly modified from Milstone (24). 
le Methods, Procedure and Tabulation Q6 Results 
The f'ibrin clots were prepared in Wasserman tub s 
via .2 ml of' the bovine fibrinogen solution to Which was ad 
2 drops of a bovine thrombin concentrate containing 1000 N. 
units per ml. The plasminogen and fibrinogen were 
of the staprrylokinase prepared in serial dilution before th 
formation of the clot (i.e., before the addition of the thrombin 
fraction). The Wasserman $ubes were thoroughly shaken, the 
thrombinconcentrate .added and the time of clot formation ( a few 
seconds) noted. The time of fibrinolysis was recorded as the 
time from initial clot formation to that of' complete clot lysis 
·as noted by the complete liquefaction of the clot _[4 +lysii}. 
The plasminogen preparations used, the volumes added, the 
order of the addition and the results are-tabulated in figures 
5 and 6 below. The degree of clot lysis is recorded as follows: 
(1) t+J 
(2) [++J 
(3) C+++J 
( 4 ) [:t- +- ·H-J 
.. sliding clot; 
... 1/2 tube liquid; 
.::; tiny floating; 
~no visible clot. 
Fig. 5 Method for fibrinolytic determinations using four plasmin-
ogen sources activated ~ the ~ staphylokinase pre-
a) 
paration. · r--
! horse serum. b) human plasma 
.5 ml·staphlykinase •• serial dil. i 
• 2 ml horse serum 
.5 ml staPhylokinase ••••• 
serial dil .. 
/7~-. 
• 6 ml PO~saline buffer,pH~7.4 
.2 ml bovine fibrinogen. 
• 2 ml human plas~a 
~.2+.6J:.8 ml POcf-saline buffer 
220 mg bovine 
fraction r*50 m1 
.85% NaCl 
2 to 3 drops bovine topical 
thrombin ••• 1000 NIH units/ml 
2 to 3 drops thrombin I 
*The further addition of fib~in­
ogen is unnecessary, as human 
plasma is used here. 
-..............,_.,.,,._.~.~----- '-'---4-·-~ _ _,_ "'- --~--,"-· ------~-- ... .., ...... ~ ..... ---· .• _....,.. .• __________ ,........________ --------------------------------- ----~-·-··--··· -··-···---
c) Remmert ~ Cohen 
.5 m1 staphylokinase •.• 
serial dil • 
• 2 m1 Re!!!ID-ert and Cohen prep. 
.6 ml PO{-saline buffer, pH~7.4 
.2 ml bovine fibrinogen 
2 to 3 drops thrombin 
d) Kaulla (ppt. f'rom pH:6) 
.5 m1 staphylokinase 
.2 m1 Kaulla(a partial 
_ suspension) 
.6 ml POfsaline buffer, 
pH~7.4 
.2 m1 bovine fibrinogen, 
f'raction I 
2 to 3 drops thrombin 
All dilution made with .1M PO!f= -. 9% saline buffer, pH =7 .. 4 
Final volume in all fibrinolysis determinations is 1.5 m.1 
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2. Fibrinolytic activity £! ~ fraction precipitated at 
ph=:5 from Kaulla procedure 
One fraction precipitated at pH=5 in Kaulla (22) was 
. "'""' not discarded, as called for~the original ?rocedure, but was 
dried in a dessicator and set aside in the cold at -4°0. to 
-6°0. Since the final active fraction wa~ precipitated from the 
supern~tant layeD of the fraction precipitated above, and es-
pecially since this active fraction was obtained at pH~6 ( a 
difference of but one pH unit and yet the separation of an 
active from an inactive fraction), it was felt advisable to test 
the fibrinolytic activity of both fractions. 
The fraction obtained at pH~s was taken up in 1/10 volume 
buffer, pH::-7. 4 (20 to 22 mls), and its fibrinolytic act.i vi ty 
tested in duplicate. The same staphylokinase preparation in the 
identical dilutions used previously and the same volumes of 
buffer, thrombin and fibrinogen from the prepared stock solutions 
used previously were employed. T.he only new factor introduced 
was the plasminogen source. In one set of tubes no clots / 
appeared upon the addition of thrombin, while in !he dup1icate a 
solid clot formed in dilutions up to 1:4 of the kinase, w.hile 
at the higher dilutions of the kinase, sliding clots and 1#2 
liquefied clots appeared and at the highest dilutions used, no 
clot .formation took place at all. The tubes were allowed to 
stand at room temperature and it was noted that the lysis was 
directly proportional tot he .kinase concentrat~on [or inversely 
proportional to kina~e dilution]. At the end of 1 to 1 1/2 hours 
all clots were completely liquefied. 
As the above were preliminary tests /and the stock prepar-
--I ---
at ions used (i.e., fibrinogen, thrombin and buf'.fer) were the 
same as employed earlier, no controls were run. Consequently, 
the only new material introduced was the source o.f plasminogen. 
In an attempt to repeat these results, the identical procedure 
was run the .following day with the same solutions. The earlier 
results could not be duplicated, however, and a second and 
third attempt at veri.fication on .following days similarly 
. 
failed. T.his would seem to indicate that either the first 
results were totally incorrect or that the particular source 
of' plasminogen employed was exceedingly unstable in solution. 
Kaulla {22) found that "acid-plasminu is very unstable in sol-
ution and is rapidly inactivated. 
A possible explanation for the earlier .findings would be 
the presence of' staphylocoagulase in the kinase preparation. 
Consequently, a series o.f Wasserman tubes were set up with the 
same kinase in serial dilutions, the identical buf'.fer, .fibrinogen 
and plasminogen source, but no thrombin was added to either the 
series containing the Kaulla fraction (.from pH=5.0 ) or the 
Remmert and Cohen preparation. There was no indication of' clot 
.formation in any tube over a test period of' six hours. T.he ae-
tion o.f coagulase may therefore be disregarded in the series of' 
fibrinolytic experiments performed here. Therefore the possib-
ility that the earlier observation (i.e., the higher the con-
centration of' kinase, the longer the clot lysis time) was due 
to the higher concentration of' coagulases in the tube contain-
ing the higher kinase concentration, may be discarded. T.hese 
results also indicate that the staphylokinase may be isolated .free 
o.f the staphylocoagulase. 
·-· 
In the preliminary experiments conducted by Loomis, George 
and Ryder (23) it was found that the plasminogen preparations 
clotted fibrinogen. Tagnon (34) noted the same activity. How~ 
ever, later findings (23) showed that the clotting property of 
the lY,tic aiding fraction could be removed by the previous re-
moval of the prothrombin from the unfractionated plasma by 
adsorption on Mg(OH)~ and centrifugation4 In none of the ex-
periments conducted in this paper was there any evidence of 
clot formation in the presence of either the kinase or plasmin-
ogen or both, before the additon of the thrombin concentrate. 
No explanation of the earlier findings is offered. However, 
two possibilities have been discarded. 
3. Fibrinolysis ~· Caseinolysis 
a. Methods and Tabulation of Results 
The possible relationship between the fibrinolytic 
and caseinolytic activities of the most active plasminogen 
fraction; i.e., the Remmert and Cohen preparation, was next 
determined. The caseinolytic and fibrinolytic experiments 
(described previously) were. run simultaneausly (the plasminogen, 
kinase and buffer in both dete~inations were taken from the 
same stock preparations). Casein hydrolysis (i.e., as deter-
mined from the acid-soluble tyrosine assays run after a pre-
liminary plasminogen-kinase activation period or'~~ hours 
:f'ollowed by a 1-hour test period) proved to be n.~ligible (fig. 5d) 
despite the use of undiluted kinase. The f'ibr~iytio tests 
(fig. 7A), however, demonstrated that 5 ml .p t 
• o.L ~e k:lna.se <lllu,.. 
t:ed 1.::8 -to 1:~6 was capable . ~ 
ot produatag clot lfsi 
1i!JJ~ 
· IIOUJI!. 
~ 
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a period in which both plasminogen-kinase activation and 
fibrinolysis had occurred. These findings agree with Shino-
wara (33), who suggested that caseinolytic and fibrinolytic 
activities are not the result of the same enzyme system. 
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b. Conclusions 
T.he controls ( fig. 7c) indicate that the assay period 
used, i.e., 3 to 4 hours, eliminated possible bacterial contam-
ination from consideration. It was evident that ribrinolysis 
took place in all the tubes with activated plasminogen, since the 
clots in all these tubes lysed more rapidly than the control 
clots. This demonstration or complete clot lysis but negligible 
caseinolysis (as assayed via the acid~soluble tyrosine production), 
agrees with Shinowara (33), who suggests "that the liqueraction 
or a ribrin clot ••• and the increase in acid soluble nitrogen are 
~ representative or an identical enzyme system. rt 
C .. Lack of· Demonstrable Coagulase .Activity !!! the Staphylokin-
~ Preparation 
The unit of lytic activity in all fibrinolytic assays per-
formed here was defined as the highest dilution or staphylokin-
ase producing complete lysis 4+ in the respective plasminogen 
preparations; the same st~hylokinase preparation was used in 
all the assays perrormed •. .As the coagulative-aiding property 
of staphylococci would tend toward tight clot rormation, the 
activity or the lytic aiding fraction might be masked completely 
during the four-hour assay period. It would be dirficult to 
evaluate the results, as the kinetics of the coagulative and 
lytic aiding propeDties of staphylococci, when both are present 
in unknown concentrations during the ribrinolysis assay, has 
not been determined. It has been demonstrated that there was 
no demonstrable coagulase activity in the previous ribrinolytic 
- -
assays.. There.fore, tight clots in the presence of plasminogen 
and high kinase titers cannot be associated with a correspond-
ingly high coagulase titer. The previous coagulase tests were 
performed merely in the presence o.f the bovine .fibrinogen. 
Gerheim, Ferguson, et al (15}, however, concluded that 
s_taphylocoagulation is produced by prostaphylocoagulase (the 
bacterial extoxin) plus a. plasma cofactor other than thrombin. 
Consequently, ~ther tests were performed to ascertain the 
e.f.fect o.f the undiluted kinase upon several samples o.f .freshly 
prepared human plaama. 
Demonstration that .the kinase preparation lacks coagulative 
aiding activity ~ human plasma 
(The method em~loyed was modified .from Walker, Derow and 
Schae.f er ( 41 ~ () 
.5 ml of the staphylokinase preparation were added 
respectively to six Wasserman test tubes containing .5 ml 
o.f .freShly prepared human plasma. The tubes were then incubatea 
II 
at 37 a. and checked every 30 seconds .for a period o.f 15 minutes, 
and at longer intervals over.a period o.f six hours. Examination 
.for any longer period would be useless, as the plasminogen-
kinase activation would have lysed the .fibrinogen and/or .fibrin. 
At no time was there any evidence o.f clot .formation in any 
tube. These .findings indicate that it is possible to isolate 
the kinase .free o.f the procoagulase. Gerheim, Ferguson et al 
(15) demonstrated that the two .factors could successfully be 
separated by incubation, as the staphlocoagulase is thermo-
labile. 
. 0 
It was shown that incubation at 75 C • .for 2 hours 
destroyed all coagulase-aiding properties while the clot lysis 
time of the same material was little altered. These findings 
indicate the separability of the coagulative and lytic aiding 
pnpperties associated with staphylococci. 
v. Summary 
Plasminogen :fractionated :from normal horse serum and acti-
vated by a staphylokinase preparation has been shown to exhibit 
considerable :fibrinolytic activity. The material obtained via 
a modified Remmert and Cohen procedure possessed considerably 
greater activity than the un:fractionated serum, but the nacid-
plasmintt obtained from a sample of the same serum via the mod-
ified Kaulla fractionation procedure exhibited negligible, if 
any, fibrinolytic activity. UD is apparent that in.the modified 
Kaulla procedure employed the active material was·either lost 
in one of the discarded fractions, or was completely inactivated. 
(3,4,5). Neither plasminogen preparation produced any demon-
strable increase in the acid-soluble tyrosine produced in a 
.7% casein solution. Here we are in agreament with Shinowara 
(33), in suggesting "that the liquefaction of a fibrin clot ••• 
and the increase in acid-soluble nitrogen are not representative 
of an identical enzyme system. u The staphylokinase preparation, 
used as plasminogen activator throughout, has been shown to be 
free of the coagulative-aiding fraction. Ferguson, Travis and 
Gerheim (15) previously demonstrated that these two properties 
associated with staphylococci were distinct by destroying the 
rl activity of the staphylocoagulase at 75 17 0 for 2 hours; the 
clot lysis t~e was little altered. It has been :found that 
plasminogen fractionated from horse serum possesses considerable 
fibrinolytic but little caseinolytic activity. 
~7 
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